Dr. Samuel Myers is Senior Molecular Biologist within Epitopea’s vaccine technology team. He received his PhD in Stem Cell Biology and Medicine from the University of Cambridge where he studied human naive pluripotency.

Since obtaining his doctorate, Samuel’s focus has been early-stage drug discovery and technology development.

This has led him to build tools and assays that have been applied to a range of cancer and degenerative disease programs during his time at Horizon Discovery, Mogrify and Epitopea.